Literature DB >> 7597380

Glycosylation of IgG during potentially arthritogenic lentiviral infections.

J McCulloch1, Y W Zhang, M Dawson, G D Harkiss, E Peterhans, H R Vogt, P M Lydyard, G A Rook.   

Abstract

Agalactosyl IgG [Gal(0)] was first discovered in patients with rheumatoid arthritis (RA). However, the proportion of this glycoform is also raised in tuberculosis and leprosy. This has helped reinforce the suggestion that RA may be triggered by a mycobacterium-like slow bacterial infection. On the other hand, arthritis can occur in mycobacterial diseases, so raised Gal(0) could be associated with a tendency to arthritis, rather than with a particular type of infection. Therefore, we wished to find out whether the percentage of Gal(0) [%Gal(0)] is increased in sheep and goats following infection with maedi visna virus or caprine arthritis encephalitis virus (CAEV), both of which can lead to inflammatory synovitis. We found that the normal level of Gal(0) in these species is much lower than in humans. Goats infected with CAEV or Mycobacterium paratuberculosis (used as a control mycobacterial infection) had a significant increase in %Gal(0), though it was still below the level seen in normal humans. Studies by Western blot confirmed the presence of terminal N-acetylglucosamine on heavy chains, and percentages of Gal(0) comparable to those seen in human RA could be generated by exposing goat IgG to streptococcal beta-galactosidase. The rise in %Gal(0) was greatest in members of infected herds that were just starting to manifest arthritis, and tended to be lower in those in which severe carpitis had developed at the time of bleeding, implying the possibility that raise %Gal(0) may be an early or predisposing event for the development of arthritis.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7597380     DOI: 10.1007/BF00262090

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  26 in total

1.  Lymphocytes from patients with rheumatoid arthritis produce agalactosylated IgG in vitro.

Authors:  K B Bodman; N Sumar; L E Mackenzie; D A Isenberg; F C Hay; I M Roitt; P M Lydyard
Journal:  Clin Exp Immunol       Date:  1992-06       Impact factor: 4.330

Review 2.  Infection as a cause of arthritis.

Authors:  L W Moreland; W J Koopman
Journal:  Curr Opin Rheumatol       Date:  1991-08       Impact factor: 5.006

Review 3.  Do stress proteins play a role in arthritis and autoimmunity?

Authors:  J Winfield; W Jarjour
Journal:  Immunol Rev       Date:  1991-06       Impact factor: 12.988

4.  A transient rise in agalactosyl IgG correlating with free interleukin 2 receptors, during episodes of erythema nodosum leprosum.

Authors:  E Filley; A Andreoli; J Steele; M Waters; D Wagner; D Nelson; K Tung; T Rademacher; R Dwek; G A Rook
Journal:  Clin Exp Immunol       Date:  1989-06       Impact factor: 4.330

5.  Agalactosyl IgG, antibodies to heat shock proteins, and acute rheumatic fever.

Authors:  G M Bahr; A M Yousof; H A Majeed; K Behbehani; M Lubani; R B Parekh; R A Dwek; T W Rademacher; D B Young; A Mehlert
Journal:  Ann Rheum Dis       Date:  1990-06       Impact factor: 19.103

6.  Autoimmune reactions to heat-shock proteins in pristane-induced arthritis.

Authors:  S J Thompson; G A Rook; R J Brealey; R Van der Zee; C J Elson
Journal:  Eur J Immunol       Date:  1990-11       Impact factor: 5.532

7.  Human serum amyloid P component is an invariant constituent of amyloid deposits and has a uniquely homogeneous glycostructure.

Authors:  M B Pepys; T W Rademacher; S Amatayakul-Chantler; P Williams; G E Noble; W L Hutchinson; P N Hawkins; S R Nelson; J R Gallimore; J Herbert
Journal:  Proc Natl Acad Sci U S A       Date:  1994-06-07       Impact factor: 11.205

8.  Early agalactosylation of IgG is associated with a more progressive disease course in patients with rheumatoid arthritis: results of a follow-up study.

Authors:  D van Zeben; G A Rook; J M Hazes; A H Zwinderman; Y Zhang; S Ghelani; T W Rademacher; F C Breedveld
Journal:  Br J Rheumatol       Date:  1994-01

9.  Agalactosyl glycoforms of IgG autoantibodies are pathogenic.

Authors:  T W Rademacher; P Williams; R A Dwek
Journal:  Proc Natl Acad Sci U S A       Date:  1994-06-21       Impact factor: 11.205

10.  Galactosylation of IgG associated oligosaccharides: reduction in patients with adult and juvenile onset rheumatoid arthritis and relation to disease activity.

Authors:  R B Parekh; I M Roitt; D A Isenberg; R A Dwek; B M Ansell; T W Rademacher
Journal:  Lancet       Date:  1988-04-30       Impact factor: 79.321

View more
  4 in total

1.  The history of IgG glycosylation and where we are now.

Authors:  Brian A Cobb
Journal:  Glycobiology       Date:  2020-03-20       Impact factor: 4.313

2.  Agalactosyl IgG and materno-fetal transmission of autoimmune neonatal lupus.

Authors:  C Pilkington; P V Taylor; E Silverman; D A Isenberg; A M Costello; G A Rook
Journal:  Rheumatol Int       Date:  1996       Impact factor: 2.631

Review 3.  Infectome: a platform to trace infectious triggers of autoimmunity.

Authors:  Dimitrios P Bogdanos; Daniel S Smyk; Pietro Invernizzi; Eirini I Rigopoulou; Miri Blank; Shideh Pouria; Yehuda Shoenfeld
Journal:  Autoimmun Rev       Date:  2012-12-22       Impact factor: 9.754

Review 4.  Tracing environmental markers of autoimmunity: introducing the infectome.

Authors:  Dimitrios P Bogdanos; Daniel S Smyk; Pietro Invernizzi; Eirini I Rigopoulou; Miri Blank; Lazaros Sakkas; Shideh Pouria; Yehuda Shoenfeld
Journal:  Immunol Res       Date:  2013-07       Impact factor: 2.829

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.